ZA964517B - Oral pharmaceutical composition of piperidinoalkanol compounds in solution form - Google Patents

Oral pharmaceutical composition of piperidinoalkanol compounds in solution form

Info

Publication number
ZA964517B
ZA964517B ZA964517A ZA964517A ZA964517B ZA 964517 B ZA964517 B ZA 964517B ZA 964517 A ZA964517 A ZA 964517A ZA 964517 A ZA964517 A ZA 964517A ZA 964517 B ZA964517 B ZA 964517B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
oral pharmaceutical
solution form
piperidinoalkanol compounds
piperidinoalkanol
Prior art date
Application number
ZA964517A
Other languages
English (en)
Inventor
Thomas T Ortyl
Paul F Skultety
Gail H Hurst
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of ZA964517B publication Critical patent/ZA964517B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
ZA964517A 1995-06-06 1996-05-31 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form ZA964517B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/469,392 US5574045A (en) 1995-06-06 1995-06-06 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form

Publications (1)

Publication Number Publication Date
ZA964517B true ZA964517B (en) 1996-12-09

Family

ID=23863607

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA964517A ZA964517B (en) 1995-06-06 1996-05-31 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form

Country Status (22)

Country Link
US (1) US5574045A (pt)
EP (1) EP0831820B1 (pt)
JP (1) JP4091655B2 (pt)
KR (1) KR100509316B1 (pt)
CN (1) CN1139386C (pt)
AR (1) AR002191A1 (pt)
AT (1) ATE256465T1 (pt)
AU (1) AU707218B2 (pt)
CA (1) CA2218643C (pt)
DE (1) DE69631132T2 (pt)
DK (1) DK0831820T3 (pt)
ES (1) ES2211954T3 (pt)
HU (1) HU227710B1 (pt)
IL (1) IL118525A (pt)
MX (1) MX9709453A (pt)
NO (1) NO318029B1 (pt)
NZ (1) NZ307370A (pt)
PT (1) PT831820E (pt)
SI (1) SI0831820T1 (pt)
TW (1) TW460283B (pt)
WO (1) WO1996039139A1 (pt)
ZA (1) ZA964517B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
JPH10500134A (ja) * 1994-05-18 1998-01-06 ヘキスト・マリオン・ルセル・インコーポレイテツド 抗ヒスタミン性ピペリジン誘導体の無水および水和形態、それらの多形態および擬似形態の製造方法
CA2213700C (en) * 1995-02-28 2002-04-02 Hoechst Marion Roussel, Inc. Pharmaceutical composition for piperidinoalkanol compounds
ES2107375B1 (es) * 1995-08-01 1998-07-01 Almirall Prodesfarma Sa Formulaciones farmaceuticas liquidas de ebastina por via oral.
US6451815B1 (en) 1997-08-14 2002-09-17 Aventis Pharmaceuticals Inc. Method of enhancing bioavailability of fexofenadine and its derivatives
CZ295461B6 (cs) * 1997-08-26 2005-08-17 Aventis Pharmaceuticals Inc. Farmaceutický prostředek ve formě dvouvrstvé tablety
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
US6613906B1 (en) 2000-06-06 2003-09-02 Geneva Pharmaceuticals, Inc. Crystal modification
US20060205752A1 (en) * 2005-03-14 2006-09-14 Keith Whitehead Stabilized hydrocodone pharmaceutical compositions with ethylenediaminetetraacetic acid

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US3806526A (en) * 1972-01-28 1974-04-23 Richardson Merrell Inc 1-aroylalkyl-4-diphenylmethyl piperidines
US3966949A (en) * 1973-10-12 1976-06-29 Richardson-Merrell Inc. Pharmaceutical compositions and preparing same
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4254130A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4285958A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof
US4285957A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
EP0111114A3 (de) * 1982-11-06 1985-10-09 Telefonbau und Normalzeit GmbH Schaltungsanordnung für eine Fernsprechvermittlungsanlage, insbesondere Fernsprechnebenstellenanlage mit zusätzlichem Datenverkehr
DK164642C (da) * 1984-08-30 1992-12-14 Merrell Dow Pharma Farmaceutisk middel indeholdende terfenadin i form af en varmsmelte paafyldt paa kapsler
US4929605A (en) * 1987-10-07 1990-05-29 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol derivatives
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
ZA90341B (en) * 1989-01-23 1990-10-31 Merrell Dow Pharma Liquid pharmaceutical composition for piperidinoalkanol derivatives
US4966061A (en) * 1989-03-27 1990-10-30 Riera John F Tube cutting apparatus

Also Published As

Publication number Publication date
KR19990022504A (ko) 1999-03-25
CN1139386C (zh) 2004-02-25
ATE256465T1 (de) 2004-01-15
PT831820E (pt) 2004-05-31
DE69631132D1 (de) 2004-01-29
NO975680D0 (no) 1997-12-05
CA2218643A1 (en) 1996-12-12
CN1187125A (zh) 1998-07-08
ES2211954T3 (es) 2004-07-16
HUP9802096A2 (hu) 1999-01-28
NO975680L (no) 1998-02-05
US5574045A (en) 1996-11-12
CA2218643C (en) 2001-12-11
IL118525A0 (en) 1996-10-16
SI0831820T1 (en) 2004-04-30
HU227710B1 (en) 2011-12-28
TW460283B (en) 2001-10-21
EP0831820A1 (en) 1998-04-01
EP0831820B1 (en) 2003-12-17
DE69631132T2 (de) 2004-08-19
IL118525A (en) 2001-07-24
AU5669596A (en) 1996-12-24
JPH11506115A (ja) 1999-06-02
AU707218B2 (en) 1999-07-08
HUP9802096A3 (en) 1999-06-28
AR002191A1 (es) 1998-01-07
WO1996039139A1 (en) 1996-12-12
NO318029B1 (no) 2005-01-24
NZ307370A (en) 1999-07-29
DK0831820T3 (da) 2004-04-13
MX9709453A (es) 1998-02-28
KR100509316B1 (ko) 2005-11-25
JP4091655B2 (ja) 2008-05-28

Similar Documents

Publication Publication Date Title
IL117237A (en) Pharmaceutical compositions of piperidinoalkanol compounds in solid unit dosage form
HUP9802999A3 (en) Pharmaceutical composition containing n-propargyl-1-aminoindan
ATE284695T1 (de) Oral anzuwendende arzneizusammensetzung enthaltend 2-methyl-thienobenzodiazepin
HUP9602056A2 (en) Novel pharmaceutical composition containing phenofibrate
IL116957A0 (en) Substituted heterocyclic compounds their preparation and pharmaceutical compositions containing them
IL122618A0 (en) Substituted imidazolylacetonitrile compounds their preparation and pharmaceutical compositions containing them
IL117265A (en) Benzazepine- benzoxazepine- and benzothiazepine-N-acetic acid derivatives their preparation and pharmaceutical compositions containing them
ZA969248B (en) New aminoacid derivatives process for the manufacture thereof and pharmaceutical compositions containing thesse compounds
IL118637A (en) Oral pharmaceutical compositions of s(+)-ibuprofen
IL117041A0 (en) Oral pharmaceutical dosage form
IL117193A0 (en) Poly-pyrrolecarbox-amidenaphthalenic acid derivatives their preparation and pharmaceutical compositions containing them
HUP0100731A3 (en) New oxazolidine-, thiazolidine-, pyrrolidine-and piperidin derivatives process for their preparation and pharmaceutical compositions containing them
IL117860A0 (en) Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them
HUP9903407A3 (en) Oral pharmaceutical preparation containing ibandronat
IL122293A0 (en) Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them
IL122717A0 (en) Compounds and pharmaceutical compositions containing them
HUP9801995A3 (en) Substituted pyrimidine-thioalkyl and alkylether compounds and their use for producing pharmaceutical compositions
IL119559A0 (en) Purin -6- one derivatives their preparation and pharmaceutical compositions containing them
IL115905A0 (en) Sordarin derivatives their preparation and pharmaceutical compositions containing them
IL118636A (en) Oral pharmaceutical compositions of S(+)-etodolac
HUP9801749A3 (en) Nodulisporic acid derivatives and pharmaceutical compositions containing them
IL122705A (en) 2-(4-Susbstituted)-benzylamino-2-methyl-propanamide derivatives their preparation and pharmaceutical compositions containing them
IL117554A0 (en) Imidazoquinazolines their preparation and pharmaceutical compositions containing them
IL116771A (en) 9-Substituted 2-(2-n-alkoxyphenyl) purin-6-one compounds their preparation and pharmaceutical compositions containing them
IL117817A0 (en) N-subsituted azaheterocyclic compounds their preparation and pharmaceutical compositions containing them